Stay up to date
Read more about Combinati and how we’re providing more accurate digital PCR to researchers or meet us at the next event.
In the News
Combinati Offers Digital PCR Solution For Monitoring Wastewater for SARS-CoV-2
Combinati Published in Scientific Reports: Development and Validation of a Spinal Muscular Atrophy (SMA) Genotyping Assay
Combinati Offers Unique Whole Product Digital PCR Testing Solution For COVID-19 Research
Panel Discussion: Data Interpretation in Wastewater Surveillance for SARS-CoV-2
April 15 at 10am PT/1pm ET
Detection and quantification of SARS-CoV-2 levels in wastewater can be a useful predictor of potential COVID-19 outbreaks. However, the interpretation of the surveillance data can be challenging. Join us as our panel of experts discuss the use of wastewater surveillance for SARS-CoV-2 for different communities and how that data is being used for early detection and risk mitigation.
The panel will also share their thoughts on what role wastewater-based epidemiology will play in the COVID-19 pandemic post-vaccination.
SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19
May 12 at 10am PT/1pm ET
This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).
While the determinants of COVID-19 disease severity and EPCs are poorly understood, the varied clinical manifestations of COVID-19 have directed attention to the distribution of SARS-CoV-2 in the body. Although SARS-CoV-2 RNA is most concentrated in the nasopharynx, it has also been found in numerous other tissues, raising questions about dissemination of viral RNA throughout the body as well as the role of this process in disease severity and extrapulmonary complications. Recent studies have detected low levels of SARS-CoV-2 RNA in blood and have associated RNAemia with disease severity and biomarkers of dysregulated immune response.